Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Integrated Immune-Related Bioinformatics Analysis in Glioma: Prognostic Signature's Identification and Multi-Omics Mechanisms' Exploration. | Front Genet | 2022 | 35601497 | PubTator, text mining | PubMed |
| Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer. | Biomed Res Int | 2022 | 35601155 | PubTator, text mining | PubMed |
| Multi-Omics Characterization of a Glycerolipid Metabolism-Related Gene Enrichment Score in Colon Cancer. | Front Oncol | 2022 | 35600382 | PubTator, text mining | PubMed |
| The product of BMP-directed differentiation protocols for human primed pluripotent stem cells is placental trophoblast and not amnion. | Stem Cell Reports | 2022 | 35594861 | PubTator, text mining | PubMed |
| Identifying tumor antigens and immuno-subtyping in colon adenocarcinoma to facilitate the development of mRNA vaccine. | Cancer Med | 2022 | 35593226 | PubTator, text mining | PubMed |
| Spatially resolved transcriptomics provide a new method for cancer research. | J Exp Clin Cancer Res | 2022 | 35590346 | PubTator, text mining | PubMed |
| Evaluation of cfDNA as an early detection assay for dense tissue breast cancer. | Sci Rep | 2022 | 35589867 | PubTator, text mining | PubMed |
| In vitro preliminary study on different anti-PD-1 antibody concentrations on T cells activation. | Sci Rep | 2022 | 35589776 | PubTator, text mining | PubMed |
| Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2. | Front Genet | 2022 | 35586565 | PubTator, text mining | PubMed |
| Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy. | Front Immunol | 2022 | 35585975 | PubTator, text mining | PubMed |
| Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer. | J Pharm Anal | 2022 | 35582397 | PubTator, text mining | PubMed |
| The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination. | Front Endocrinol (Lausanne) | 2022 | 35574025 | PubTator, text mining | PubMed |
| Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma. | Transl Cancer Res | 2022 | 35571648 | PubTator, text mining | PubMed |
| The value of WNT5A as prognostic and immunological biomarker in pan-cancer. | Ann Transl Med | 2022 | 35571400 | PubTator, text mining | PubMed |
| Silencing of B7H4 Represses the Development of Oral Squamous Cell Carcinoma Through Promotion of M1 Macrophage Polarization. | J Oral Maxillofac Surg | 2022 | 35568099 | PubTator, text mining | PubMed |
| Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy. | Cancers (Basel) | 2022 | 35565348 | PubTator, text mining | PubMed |
| Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer. | Cells | 2022 | 35563856 | PubTator, text mining | PubMed |
| B7-H4 Immune Checkpoint Protein Affects Viability and Targeted Therapy of Renal Cancer Cells. | Cells | 2022 | 35563753 | PubTator, text mining | PubMed |
| Insight into the Role of Psychological Factors in Oral Mucosa Diseases. | Int J Mol Sci | 2022 | 35563151 | PubTator, text mining | PubMed |
| Potential mechanisms and therapeutic targets of mesenchymal stem cell transplantation for ischemic stroke. | Stem Cell Res Ther | 2022 | 35551643 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=43